Clinical Trials Logo

Macular Edema Due to BRVO/CRVO clinical trials

View clinical trials related to Macular Edema Due to BRVO/CRVO.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT01968616 Recruiting - Clinical trials for Macular Edema Due to BRVO/CRVO

Ranibizumab Treatment for Retinal Vein Occlusion

Start date: September 2013
Phase: N/A
Study type: Interventional

In retinal vein occlusion, predictive factors for visual outcome after ranibizumab treatment have not been evaluated comprehensively. Therefore, we have planned to analyze predictors for visual outcome from a viewpoint of electrophysiology and biomarkers besides morphological features by SD-OCT.